NEW MILTON, United Kingdom--(BUSINESS WIRE)--Genetix Group plc (AIM:GTX) (“Genetix” or the “Company”), a leading developer of technologies for automated, high throughput cell identification and selection for the pharmaceutical, biotechnology and clinical diagnostics industries, announces the appointment of Jerry Williamson as President of U.S. Operations.
